Pharmacokinetics of meropenem in the patients with burn injury

Chinese Journal of Antibiotics

Volumn 29, Issue 2, 2004, Pages 118-123

  Lin, Cai ^a   Liu, Song Qing ^a   Dai, Qing ^a   He, Jun Ying ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Burn injury; MBC; Meropenem; MIC; Pharmacokinetics

Indexed keywords

MEROPENEM;

AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; BURN; CLINICAL ARTICLE; COMPARTMENT MODEL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG HALF LIFE; DRUG URINE LEVEL; HUMAN; PARAMETER; PHARMACOKINETICS; SINGLE DRUG DOSE; URINALYSIS; URINARY EXCRETION;

EID: 1942520230     PISSN: 10018689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Pfaller M A, Jones R N. A review of the in vitro activity of meropenem and comparative antimicrobial agents tested against 30, 254 aerobic and anaerobic pathogens isolated world wide [J]. Diagn Microbiol Infect Dis, 1997, 28(4): 157
2. Hutchison M, Faulkner K L, Turner P J, et al. A compilation of meropenem tissue distribution date[J]. J Antimicrob Chemother, 1995, 36, (Suppl A): 43
3. Leroy A, Fillastre J P, Borsa-Lebas F, et al. Pharmacokinetics of meropenem (ICI 194, 660) and its metabolite (ICI 213, 689) in healthy subjects and in patients with renal impairment [J]. Antmicrob Agents Chemother, 1992, 36(12): 2794
4. Chimata M, Nagase M, Suzuki Y, et al. Pharmacokinetics of meropenem in patients with various degrees of renal function, including patients with end-stage renal disease[J]. Antimicrob Agents Chemother, 1993, 37(2): 229
5. Weinbren M J. Pharmacokinetics of antibiotics in burn patients [J]. J Antimicrob Chemother, 1999, 44(2): 319
6. Hanberger H, Svensson E, Nilsson L E, et al. Control-related effective regrowth time and post-antibiotic effect of meropenem on Gram-negative bacteria studied by bioluminescence and viable counts[J]. J Antimicrob Chemother, 1995, 35(5): 585
7. Moon Y S K, Chung K C, Gill M A. Pharmacokinetics of meropenem in animals, healthy volunteers, and patients [J]. Clin Infect Dis, 1997, 24 (Suppl 2): S249